Pathology of Penicillium marneffei: An emerging acquired immunodeficiency syndrome-related pathogen

Archives of Pathology and Laboratory Medicine

Volumn 121, Issue 8, 1997, Pages 798-804

  Cooper, Chester R ^a   McGinnis, Michael R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PENICILLIUM MARNEFFEI; SEROLOGY; SKIN MANIFESTATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; ASIA, SOUTHEASTERN; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; MICROBIAL SENSITIVITY TESTS; MYCOSES; PENICILLIUM; SEROLOGIC TESTS; SKIN DISEASES;

EID: 0342437517     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Anaissie E, Bodey GP, Kantarjian H, et al. New spectrum of fungal infections in patients with cancer. Rev Infect Dis. 1989;11:369-378.
2. Ampel NM. Emerging disease issues and fungal pathogens associated with HIV infection. Emerging Infect Dis. 1996;2:109-116.
3. Dixon DM, McNeil MM, Cohen ML, Gellin BG, La Montagne JR. Fungal infections: a growing threat. Public Health Rep. 1996;111:226-235.
4. Perfect JR, Schell WA. The new fungal opportunists are coming. Clin Infect Dis. 1996;22:S112-S118.
5. Drouhet E. Penicilliosis due to Penicillium marneffei: a new emerging systemic mycosis in AIDS patients travelling or living in Southeast Asia: review of 44 cases reported in HIV infected patients during the last 5 years compared to 44 cases of non AIDS patients reported over 20 years. J Mycol Med. 1993;4:195-224.
6. Drouhet E, Dupont B. Infection a Penicillium marneffei: mycose systémique a manifestations cutanées associée au SIDA. J Mycol Med. 1955;5:21-34.
7. Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis. 1996;23:125-130.
8. Imwidthaya P. Update of penicilliosis marneffei in Thailand. Mycopathologia. 1994;127:135-137. Review.
9. McGinnis MR. Penicillium marneffei, dimorphic fungus of increasing importance, Clin Microbiol Newsl. 1994;16:29-31.
10. Sirisanthana T. Disseminated Penicillium marneffei infection in patiente with acquired immunodeficiency syndrome, Jpn j Med Mycol. 1996;37:5-8.
11. Wortman PD. Infection with Penicillium marnffei. Int J Dermatol. 1996; 35:393-399.
12. Li PC, Tsui MC, Ma KF. Penicillium marneffei: indicator disease for AIDS in Soyth East Asia. AIDS. 1992;6:240-241.
13. Wong KH, Lee SS, Lo YC, et al. Profile of opportunistic infections among HIV-1 infected people in Hong Kong. Chin Med J. 1995;55:127-136.
14. Lee SS, Lo YC, Wong KH. The first one hundred AIDS in Hong Kong. Chin Med J. 1996;109:70-76.
15. Chariyalertsak S. Epidemiology and Risk factors Associated With Penicillium marneffei Infections in HIV-Infected Patients in the North of Thailand. Baltimore, Md: Johns Hopkins University; 1996. Dissertation.
16. Chariyalertsak S, Sirisanthana T, Supparatpinyo K, Nelson KE. Seasonal variation of disseminated Penicillium marneffei infections in northern Thailand: a due to the reservoir? J Infect Dis. 1996;173:1490-1493.
17. Brown T, Sittitrai W, Vanichseni S, Thisyakorn U. The recent epidemiology of HIV and AIDS in Thailand. AIDS. 1994;8:S131-S141.
18. Phillips P. Penicillium marneffei part of Southeast Asian AIDS. JAMA. 1996; 276:86-87.
19. Yuen KY, Wong SS, Tsang DN, Chau PY. Serodiagnosis of Penicillium marneffei infection. lancet. 1994;344:444-445.
20. Jones PD, See J. Penicillium marneffei infection in patients infected with human immunodeficiency virus: late presentation in an area of nonendemicity. Clin Infect Dis. 1992;15:744.
21. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet. 1994;344: 110-113.
22. Yuen WC, Chan YF, Loke SL, Seto WH, Poon GP, Wong KK. Chronic lymphadenopathy caused by Penicillium marneffei: a condition mimicking tuberculous lymphadenopathy. Br J Surg. 1986;73:1007-1008.
23. Deng ZL, Yun M, Ajello L. Human peniciiliosis marneffei and its relation to the bamboo rat (Rhizomys pruinosus). J Med Vet Mycol. 1986;24:383-389.
24. Deng ZL, Connor DH. Progressive disseminated penicilliosis caused by Penicillium marneffei: report of eight cases and differentiation of the causative organism from Histoplasma capsulatum. Am J Clin Pathol. 1985;84:323-327.
25. Jayanetra P, Nitiyanant P, Ajello L, et al. Penicilliosis marneffei in Thailand: report of five human cases. Am J Trop Med Hyg. 1984;33:637-644.
26. Li JS, Pan LQ, Wu SX, Su SX, Su SB, Shan LY. Disseminated penicilliosis marneffei in China: report of three cases. Chin Med J, 1991;104:247-251.
27. Chandler FW, Watts JC, Pathologic Dignosis of Fungal Infections. Chicago, III: ASCP Press; 1987.
28. Gordon MA. Paecilomyces lilacinus (Thom) Samson, from systemic infection in an armadillo (Dasypus novemcinctus). Sabouraudia. 1984;22:109-116.
29. Kwon-Chung KJ, Bennett JE. Medical Mycology. Philadelphia, Pa: Lea & Febiger; 1992.
30. Kaufman L, Standard PG, Jalbert M, Kantipong P, Limpakarnjanarat K, Mastro TD. Diagnostic antigenemia tests for penicilliosis marneffei. J Clin Microbiol. 1996;34:2503-2505.
31. Kaufman L, Standard PG, Anderson SA, Jalbert M, Swisher BL. Development of specific fluorescent-antibody test for tissue form of Penicillium marneffei, I Clin Microbiol. 1995;33:2136-2138.
32. Kaufman L, Standard P, Padhye AA. Exoantigen tests for the immunoidentification of fungal cultures. Mycopathologia. 1983;82:3-12.
33. Sekhon AS, Garg AK, Padhye AA, Standard PG, Kaufman L, Ajello L. Antigenic relationship of Penicillium marneffei to P. primulinum. J Med Vet Mycol. 1989;27:105-112.
34. Sekhon AS, Li JS, Garg AK. Penicilliosis marneffei: serological and exoantigen studies. Mycopathologia. 1982;77:51-57.
35. Arrese Estrada J, Stynen D, Van Cutsem J, Piérard-Franchimont C, Piérard GE. Immynohistochemical identification of Penicillium marneffei by monoclonal antibody. Int J Dematol. 1992;31:410-412.
36. Viviani MA, Tortorano AM, Rizzardini G, et al. Treatment and serological studies of an Italian case of peniciiliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus. Eur J Epidemiol. 1993;9:79-85.
37. Sekhon AS, Padhye AA, Garg AK, In vitro sensitivity of Penicillium marneffei and Pythium insdiosum to various antifungal agents. Eur J Epidemiol. 1992; 8:427-432.
38. Sekhon AS, Garg AK, Padhye AA, Hamir Z. In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole. Eur J Epidemiol, 1993;9:553-558.
39. Van Cutsem J, Van Gerven F. Activitié antifongique in vitro de I'itraconazote sur les champignons filamenteux opportunistes: traitement de la kératomycose et de la pénicilliose expérimentales, J Mycol Med. 1991;1:10-15.
40. Van Cutsem J. In-vitro- und in-vivo-Aktivität von Itraconazol. Med Klinik. 1991;86:5-8.
41. Supparatpinyo K, Nelson KE, Merz WG, et al. Response to antfungal therapy by human immynodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in-vitro susceptibilities of isolates from clinical specimens. Antimicrob Agents Chemother. 1993;37:2407-2411.
42. Sirisanthana V, Sirisanthana T. Disseminated Penicillium marneffei infection in hyman immunodeficiency virus-infected children, Pediar Infect Dis J. 1995;14:935-940.
43. Kok I, Veenstra J, Rietra PJ, Dirks-Go S, Blaaugeers JL, Weigel HM. Disseminated Penicillium marneffei infection as an imported disease in HIV-1 infected patients: description of two cases and a review of the literature. Neth J Med. 1994;44:18-22.
44. Pete TE, Bull R, Millard PR, et al. Systemic mycosis due to Penicillium marneffei in a patient with antibody to human immunodeficiency virus, J Infect. 1988;16:285-290.